Whether Sotolaxib (AMG 510) has been included in medical insurance and details of reimbursement ratio

Sotorasib is a KRAS G12C mutation-selective inhibitor, mainly used to treat patients with advanced non-small cell lung cancer (NSCLC) carrying KRAS G12C mutations. At present, sotoracib has not been officially launched in China, so it has not been included in the national medical insurance system. Domestic patients cannot obtain the drug through hospital reimbursement.

For patients who need to use sotoraxib, they can choose to obtain the drug through formal overseas channels. In the overseas market, the original drug of Sotorasibu mainly includes the European version and the Hong Kong version. The price is very expensive, ranging from RMB 40,000 to more than 100,000 yuan per box. This type of original medicine has stable efficacy and reliable ingredients, but its high price makes it difficult for most patients to maintain long-term treatment.

Compared with the original drug, the price of the generic drug sotoracib that has been launched in overseas markets is more affordable. Taking the Laos market as an example, the price of 120mg*56 generic drugs produced by Lao Lucius and Lao Daxiong companies has recently been reduced to more than 1,000 yuan. Generic drugs are basically the same as the original drugs in terms of ingredients, which can provide patients with more economical treatment options and reduce the financial pressure of long-term medication.

When patients consider obtaining sotoraxib through overseas channels, they should choose regular manufacturers or authorized pharmacies to ensure drug quality and safety. During use, you must strictly follow the doctor's instructions and take medication, regularly monitor liver function, kidney function and blood routine, and pay attention to possible adverse reactions. In addition, if sotoracib is launched in China and included in medical insurance in the future, patients will be expected to enjoy more convenient access and financial support.

Reference link:https://www.drugs.com